Showing results (2231-2240 of 2,268) with videos related to

Sort By:
Pageof 227
Epilepsia|March 30, 2019
Critique of the 2017 epileptic seizure and epilepsy classificationsHans Lüders, Naoki Akamatsu, Shahram Amina, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 30, 2026
Early Versus Delayed Anticoagulation in Acute Ischaemic Stroke with Atrial Fibrillation According to Infarct Volume and Location: a Prespecified Subgroup Analysis of the OPTIMAS Randomised Controlled TrialPhilip S Nash, Jonathan Best, James Lyon, et al.
Frontiers in Plant Science|July 23, 2016
Non-tenera Contamination and the Economic Impact of SHELL Genetic Testing in the Malaysian Independent Oil Palm IndustryLeslie C-L Ooi, Eng-Ti L Low, Meilina O Abdullah, et al.
Cancer Discovery|June 13, 2015
Co-occurring genomic alterations define major subsets of KRAS-mutant lung adenocarcinoma with distinct biology, immune profiles, and therapeutic vulnerabilitiesFerdinandos Skoulidis, Lauren A Byers, Lixia Diao, et al.
Journal of Clinical and Experimental Hepatology|May 17, 2021
The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 PatientsHarshad Devarbhavi, Tarun Joseph, Nanjegowda Sunil Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2012
An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistanceLauren Averett Byers, Lixia Diao, Jing Wang, et al.
Circulation. Arrhythmia and Electrophysiology|September 30, 2025
Dual Epicardial and Endocardial Procedure (DEEP) for Persistent or Longstanding Persistent Atrial FibrillationKenneth A Ellenbogen, Ali Khoynezhad, Mark La Meir, et al.
The Lancet. Neurology|February 21, 2026
Safety and efficacy of intensive task-specific training in people with recent spinal cord injury: a phase 3, pragmatic, randomised, assessor-blinded, superiority trialJoanne V Glinsky, Jackie Chu, Christine Rimmer, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In OncologyNadeem R Abu-Rustum, Susana M Campos, Sudha Amarnath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 12, 2025
Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026)Brian M Slomovitz, S John Weroha, Wei Deng, et al.
Pageof 227